Pre-Operative Ketamine Infusion for Post Operative Pain Control After Revision Spinal Surgery
Dr. Jessica Jameson, MD, FASA.
Medical degree, Michigan State University. Internship, David Grant US Air Force Medical Center. US Air Force Flight Surgeon. Residency in Anesthesia at the University of Iowa College of Medicine. Harvard fellowship, Pain Medicine, Beth Israel Deaconess Medical Center. Board certified in anesthesiology and pain management, American Board of Anesthesiology. Board member, American Society for Interventional Pain Physician. Co-Founder, Axis Spine Center.
To determine if a pre-operative ketamine infusion would provide a similar decrease in post-operative analgesic and opioid consumption as intra-operative ketamine, but expand the monitoring period through the post-operative phase up to 90 days. Hypothesis is that pre-operative ketamine infusion will lead to a decrease in narcotic consumption from baseline following an elective cervical or lumbar fusion, leading to increased functionality and quality of life for these patients.
Quality Improvement, Interventional, Open-Label
- Opportunity to participate in IRB-approved trial for non-opioid pain management.
- Collaborate with clinical domain thought leaders.
- Access statistically significant registry datasets supporting standards of care for pain control in context of spine surgery and post-surgical care.
- The Beck Depression Inventory (BDI)
- Oswestry Low Back Pain Disability Questionnaire
- The Numerical Opioid Side Effect (NOSE)
- EQ-5D-5L
- Brief Pain Inventory (BPI)
Private Circle
Pre-Operative Ketamine Infusion for Post Operative Pain Control After Revision Spinal Surgery
To determine if a pre-operative ketamine infusion would provide a similar decrease in post-operative analgesic and opioid consumption as intra-operative ketamine, but expand the monitoring period through the post-operative phase up to 90 days. Hypothesis is that pre-operative ketamine infusion will lead to a decrease in narcotic consumption from baseline following an elective cervical or lumbar fusion, leading to increased functionality and quality of life for these patients.
Degree of reduction in opiate consumption following surgery.
BDI; ODI; NOSE; EQ-5D-5L; BPI
Spine surgeons. Musculoskeletal clinicians. Interventional pain management clinicians. Rehabilitation specialists.
- Opportunity to participate in IRB-approved trial for non-opioid pain management.
- Collaborate with clinical domain thought leaders.
- Access statistically significant registry datasets supporting standards of care for pain control in context of spine surgery and post-surgical care.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Private Circle
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.